Balchem(BCPC)

Search documents
Balchem(BCPC) - 2024 Q1 - Earnings Call Presentation
2024-05-03 18:15
Investor Presentation Q1 2024 1 Safe Harbor Statement • During the course of this presentation, management may make forward-looking statements regarding financial performance and future events. • We will attempt to identify these statements by use of words such as expect, believe, anticipate, intend, and other words that denote future events. You should understand that, even though our forward-looking statements are based on assumptions we believe are reasonable when made, they are still subject to uncertai ...
Balchem(BCPC) - 2024 Q1 - Quarterly Results
2024-05-03 11:07
Exhibit 99.1 5 Paragon Drive Montvale, NJ 07645 p.845.326.5600 f. 845.326.5702 Human Nutrition & Health | Animal Nutrition & Health | Specialty Products Balchem Corporation Reports First Quarter 2024 Financial Results First Quarter 2024 Financial Highlights: Recent Highlights: Montvale, NJ, May 3, 2024 - Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal first quarter ended March 31, 2024. The Company reported quarterly net sales of $239.7 million, quarterly net earnings ...
New York Jets Announce Multi-Year Partnership with VitaCholine®
Newsfilter· 2024-05-02 12:00
MONTVALE, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- The New York Jets announced a partnership with VitaCholine, a Balchem Human Nutrition and Health brand of the essential nutrient choline, as Proud Partner of the team. This agreement marks VitaCholine's first sponsorship and the first sponsorship in the Nutritional Ingredient category of a major professional sports team. The multi-year agreement includes entitlement of the New York Jets official website NewYorkJets.com, grants territorial rights in both the U ...
Balchem Corporation to Attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024
Newsfilter· 2024-05-01 11:00
MONTVALE, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will attend the conference. About Balchem Corporation Balchem Corporation deve ...
Blachem (BCPC) Reports Next Week: Wall Street Expects Earnings Growth
Zacks Investment Research· 2024-04-26 15:05
Core Viewpoint - Blachem (BCPC) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with the earnings report expected on May 3, 2024, which could significantly influence the stock price depending on the actual results compared to estimates [1] Financial Expectations - The consensus estimate for Blachem's quarterly earnings is $0.94 per share, reflecting a year-over-year increase of +34.3% [2] - Expected revenues for the quarter are $235.56 million, which is a 1.3% increase from the same quarter last year [2] Estimate Revisions - The consensus EPS estimate has been revised 0.51% lower in the last 30 days, indicating a reassessment by analysts [2] - The Most Accurate Estimate for Blachem is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +4.26%, suggesting a recent bullish sentiment among analysts [5] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a favorable Zacks Rank [4] - Blachem currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat despite the positive Earnings ESP [5][6] Historical Performance - In the last reported quarter, Blachem was expected to post earnings of $0.87 per share but delivered $0.82, resulting in a surprise of -5.75% [7] - Over the past four quarters, Blachem has only beaten consensus EPS estimates once [7] Industry Comparison - Linde (LIN), another player in the Zacks Chemical - Specialty industry, is expected to report earnings of $3.68 per share, indicating a year-over-year change of +7.6% [9] - Linde's expected revenues are $8.36 billion, up 2% from the previous year, with a lower Most Accurate Estimate leading to an Earnings ESP of -0.54% [9]
Balchem Corporation Releases 2023 Sustainability Report
Newsfilter· 2024-04-22 11:00
MONTVALE, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today published its 2023 Sustainability Report, highlighting the Company's Corporate Social Responsibility initiatives and accomplishments. Guided by our core values and our vision of making the world a healthier place, our Sustainability Report demonstrates the Company's continuing promise to provide our employees, customers, shareholders and the communities within which we operate with information on Balchem's sustainabil ...
Time to Buy These Top-Rated Basic Materials Stocks Amid an Uptick in Inflationary Data
Zacks Investment Research· 2024-03-18 21:21
An uptick in inflation can of course be beneficial to many basic materials companies as they are often able to capitalize on higher commodity prices.Markets have remained resilient despite February’s CPI (Consumer Price Index) and PPI (Producer Price Index) data coming in hotter than anticipated but it may be time to consider buying several highly ranked basic materials stocks and here are a few to consider.Balchem (BCPC) Boasting a Zacks Rank #1 (Strong Buy) we’ll start with Balchem Corporation which provi ...
Is Balchem (BCPC) Outperforming Other Basic Materials Stocks This Year?
Zacks Investment Research· 2024-03-11 14:46
Group 1 - Blachem (BCPC) is currently ranked 15 in the Zacks Sector Rank for the Basic Materials group, which consists of 237 companies [1] - The Zacks Rank for Blachem is 1 (Strong Buy), indicating a positive earnings outlook [1] - Over the past 90 days, the Zacks Consensus Estimate for BCPC's full-year earnings has increased by 9.8%, reflecting improved analyst sentiment [2] Group 2 - Year-to-date, Blachem has returned approximately 5.2%, outperforming the Basic Materials sector average return of -3% [2] - Blachem belongs to the Chemical - Specialty industry, which is ranked 143 in the Zacks Industry Rank and has an average gain of 8.2% this year, indicating slight underperformance compared to its industry [3] - D S SMITH (DITHF) is another stock in the Basic Materials sector that has outperformed, with a year-to-date return of 43.7% and a Zacks Rank of 2 (Buy) [2][3]
Here's Why Momentum in Blachem (BCPC) Should Keep going
Zacks Investment Research· 2024-03-11 13:51
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done.Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate rev ...
Can Blachem (BCPC) Run Higher on Rising Earnings Estimates?
Zacks Investment Research· 2024-02-22 18:21
Core Viewpoint - Blachem (BCPC) is positioned as a strong investment opportunity due to its improving earnings outlook and analysts' increasing earnings estimates [1][2]. Current-Quarter Estimate Revisions - The earnings estimate for the current quarter is $0.95 per share, reflecting a year-over-year increase of +35.71% [3]. - Over the past 30 days, the Zacks Consensus Estimate for Blachem has risen by 5.56%, with one estimate moving higher and no negative revisions [3]. Current-Year Estimate Revisions - For the full year, Blachem is expected to earn $4.04 per share, which is a +20.6% change from the previous year [4]. - The consensus estimate for the current year has increased by 7.03%, with one estimate moving higher and no negative revisions [4]. Favorable Zacks Rank - Blachem currently holds a Zacks Rank 1 (Strong Buy) due to positive estimate revisions, indicating strong potential for stock performance [5]. - Research indicates that stocks with Zacks Rank 1 and 2 significantly outperform the S&P 500 [5]. Bottom Line - Investors have shown confidence in Blachem, evidenced by a 10% stock gain over the past four weeks, suggesting potential for further growth [6].